Heron Neutron Medical, a subsidiary of semiconductor equipment supplier Hermes-Epitek, is set to list on Taiwan’s stock market in mid-September. Heron General Manager Leo Shen stated that by integrating patented technologies from National Tsing Hua University and Taiwan’s Industrial Technology Research Institute (ITRI), the company has developed a patented accelerator-based boron neutron capture therapy (AB-BNCT) device for cancer treatment. This device received medical device certification in 2024, making Heron the first certified manufacturer in Taiwan and the second worldwide.